In collaboration with Roche, one of the world’s largest biotechnology companies, industrial technology company Emerson has developed a digital library of modalities for faster deployment and use of Emerson’s DeltaV Process Knowledge Management (PKM) …

… years off the process of drug development. Dr. David Brenner, the institute … potential liabilities earlier in the drug development process,” Brenner said in a …

… The final phases of pharmaceutical drug development represent a dramatic shift in … Late-Stage Development Late-stage drug development differs fundamentally from early-stage …

… to discover new drug development projects and strengthen … joint identification of new drug development projects, implementation of joint … the entire new drug development process from early … necessary for new drug development through collaboration with …

… is strengthening its drug development capabilities through open innovation … jointly identify new drug development projects and collaborate … across the entire drug development process, including joint … all stages of drug development, from early candidate …

… will combine their respective drug development capabilities to jointly identify … Chemicals, which is currently developing drug pipelines across various therapeutic areas … the capabilities required for drug development through partnerships with specialized …

- Advertisement - Key Takeaways: The New Valley of Death: Assets often fail now not because they miss the clinical endpoint, but because they miss the market need (reimbursement rejection). TPP to TVP: The static Target Product Profile must evolve into a “ …

The FDA has just approved Novo Nordisk’s oral Wegovy, marking a turning point in obesity treatment and answering a perpetual question: When are oral GLP-1s going to be available? The FDA nod transforms what was once a high-risk therapeutic area into one of …

… triage to risk scoring. In drug development, its potential is vast: predictive … new era of evidence generation, drug development, and human health.

… , Lambiase PD, et al. Advancing drug development for atrial fibrillation by prioritising …